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Abstract
While the probability of a woman developing invasive breast cancer at age <40 is low (<1%),
mammography use reported among younger women (age <40) is substantial, and varies by race/
ethnicity. Little detail is known about mammography use among women aged <40, particularly by
race/ethnicity. We describe racial/ethnic differences in: (1) mammography indication after
considering underlying risk factors (breast symptoms and family history); (2) follow-up
recommendations, and (3) mammography outcomes for first mammograms in women aged <40.
These 1996–2005 Breast Cancer Surveillance Consortium data are prospectively pooled from seven
U.S. mammography registries. Our community-based sample included 99,615 women aged 18–39
who self-reported race/ethnicity and presented for a first mammogram (screening or diagnostic) with
no history of breast cancer. Multivariable analyses controlled for registry site, age, family history of
breast cancer, symptoms, and exam year. Overall, 73.6% of the women in our sample were seen for
a screening mammogram. Following screening mammography, African American (AA) women were
more likely than white women to be recommended for additional workup [relative risk (RR): 1.15
(95% CI: 1.07–1.23)]. Following diagnostic mammography, AA [RR: 1.30 (95% CI: 1.17–1.44)]
and Asian [RR: 1.44 (95% CI: 1.26–1.64)] women were more likely to be recommended for biopsy,
fine-needle aspiration, or surgical consultation. Depending on race/ethnicity, and considering the
rate of true positive to total first screening mammograms of younger women, a women has a
likelihood of a true positive of 1 in 363–1,122; she has a likelihood of a false positive of 1 in 7–10.
This study of community-based practice found racial/ethnic variability in mammography indication,
recommendations, and outcomes among women undergoing first mammography before 40. These
findings highlight important areas for future research to understand the motivating factors for these
practice patterns and the implications of early mammography use.
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Introduction
Breast cancers that occur in women aged less than 40 (“younger women”) have poorer
prognostic characteristics [1], higher recurrence rates and higher relative mortality than women
≥40 [2]. Younger women and African American (AA) women are more likely to have tumors
that are triple negative (for receptors for estrogen, progesterone, and human epidermal growth
factor 2), a distinct molecular tumor subtype, basal-like, and high grade [3]. Among younger
women, AA women have a higher age-specific breast cancer incidence than white women in
the age range somewhere between 35 [4] and 40 [5,6], beyond which white women have higher
breast cancer incidence [4–6]. Hispanic, Asian, and Pacific Islander women tend to have lower
incidence rates of breast cancer than white women [6].
Although the probability of a woman aged <40 developing invasive breast cancer is low (<1%),
the use of mammography among younger women is reported to be substantial, and varies by
race/ethnicity [7]. According to a population-based study, 34% of non-Hispanic (NH) AA
women, 30% of NH white women, and 22% of Hispanic women aged 30–39 self-reported ever
having had a mammogram [8]. In another sample, 40% of AA women self-reported the age of
their first mammogram as <40 [9]. Even among younger women estimated to be at average
risk, AA women had a greater odds of self-reporting multiple mammograms compared to white
women [8]. Further, once younger women begin mammography, they may likely be
recommended to continue mammography, irrespective of risk factors [10]. Yet the continuation
of mammography recommendations may not mean continued adherence to recommended
intervals. Younger AA women were significantly more likely to self-report having a
mammogram than white women until age 34 [11]; however, among women ≥40, AA and Asian
women are less likely to receive adequate mammography screening [12].
Our knowledge from the literature of mammography use in younger women by race/ethnicity
has relied heavily on self-reported data, and often fails to distinguish screening from diagnostic
indications. This article is the first to prospectively describe mammography use in younger
women by race/ethnicity; specifically: (1) mammography indication after considering
underlying risk factors (breast symptoms and family history); (2) follow-up recommendations
after each indication, and (3) mammography outcomes. We use the National Cancer Institute’s
(NCI) Breast Cancer Surveillance Consortium [13] (BCSC) data which are rich in their
prospective design, racial/ethnic diversity, description of breast symptoms, large sample size,
and ability to distinguish mammography indications (screening and diagnostic). Describing
first mammograms in younger women by race and ethnicity is a step toward understanding
patterns of mammography use in younger women, the motivations for this use, and ultimately
the implications of very early mammography.
Methods
Data sources
The pooled BCSC data used in this study are drawn from a collaborative network of
mammography registries in North Carolina, Washington, New Hampshire, New Mexico,
California, Colorado, and Vermont. The BCSC was created to assess the performance
characteristics, delivery, and quality of breast cancer mammography utilization and outcomes
across the United States [13,14]. A Statistical Coordinating Center (SCC) oversees the
coordination, pooling, and cleaning of data from the registry sites. Each registry and the SCC
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receives ongoing IRB approval for either active or passive consenting processes or a waiver
of consent to enroll participants, link data, and perform analytic studies. All the procedures are
Health Insurance Portability and Accountability Act-compliant, and all the registries and the
SCC have received a US Public Health Service Certificate of Confidentiality and other
protection for the identities of women, physicians, and facilities who are subjects of this
research. The University of Missouri’s Health Sciences Institutional Review Board approved
this study as exempt.
Registry overview
The BCSC registries are described in greater detail elsewhere [13]. In brief, the participating
radiology practices prospectively gather information from women at each visit for breast
imaging using a self-administered patient survey. The type of information collected by site
includes: date of birth; race; ethnicity; education; history of breast procedures; personal and
first-degree family history of breast cancer; and breast symptoms. The radiologists and/or
technologists record information on the imaging studies including mammography indication
(screening or diagnostic); Breast Imaging Reporting and Data System® (BI-RADS) [15] breast
density, imaging assessments and recommendations for follow-up; prior mammography; and
use of same-day ultrasound. Each registry annually links to a state tumor registry or regional
Surveillance, Epidemiology, and End Results program that collects population-based cancer
data; some also link to pathology databases.
Subjects
We initially identified 114,317 women aged 18–39 having had a first mammogram during
1996–2005 and with no personal history of breast cancer. We excluded 1,403 (1.2%)
mammograms with unknown indication. We categorized race/ethnicity into mutually exclusive
categories of non-Hispanic AA, non-Hispanic white, Asian, and Hispanic. For brevity, we will
refer to these categories as AA, white, Asian, and Hispanic. We excluded 11,151 (9.9%) women
missing information of self-reported race or ethnicity, and 2,148 (1.9%) women reporting a
race/ethnicity not falling in any of the above categories, as the relatively small sample size
precluded further analyses. Thus, our final sample overall consisted of 99,615 women.
Measurements and definitions
We used standard BCSC definitions for classifying type of mammogram [13]. A routine-view,
bilateral mammography examination indicated for screening was considered a screening
mammogram, i.e., performed to detect unsuspected breast cancer in asymptomatic women
[16]. A mammogram indication for the evaluation of a breast problem was considered a
diagnostic mammogram, i.e., appropriate for a specific focus of clinical concern or when direct
involvement of the radiologist is required [16]. If the radiology report indicated a screening
mammogram, but the woman self-reported symptoms on the patient survey, then we a priori
chose to retain the screening classification to be consistent with community-based practice.
Patient-reported breast symptoms were categorized as the presence of a lump, discharge, pain,
symptoms not otherwise specified (NOS), or no symptoms. Patients could report more than
one symptom. BI-RADS recommendations for follow-up were classified as normal- or short-
interval; or “additional workup” [defined here as additional imaging; clinical exam; biopsy,
fine-needle aspiration (FNA) or surgical consultation; or other workup NOS]. For screening
mammography, the recommendation based on the initial screening views was used. For
diagnostic mammography, the recommendation was based on the end of diagnostic workup.
For descriptive analyses, we divided age into two groups, 18–34 and 35–39, based on historical
ACS recommendations for a baseline mammogram [17].
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We describe the distribution of patient characteristics and mammography outcomes in this
sample by race/ethnicity separately for diagnostic and screening mammograms. The primary
aims of this article are descriptive and hypothesis generating, with formal tests of significance
primarily limited to a priori-specified hypotheses regarding racial/ethnic differences in the
follow-up recommendations of screening and diagnostic mammography.
In order to identify racial/ethnic differences in the follow-up recommendations, we modeled
recommendations separately for each mammography indication, adjusting for registry site, age
(using a cubic b-spline with three knots to allow flexibility in adjusting for the age association),
examination year, first-degree family history of breast cancer, and the presence of symptoms.
We a priori chose to exclude breast density from the multivariable models due to missing data;
this was included post-hoc. We obtained estimates via estimating equations, with standard
errors calculated using the robust “sandwich estimator” [18] to produce consistent estimates
of the covariance matrix and, thus, provide valid inference. For screening exams, we used a
log-linear model to compute the relative risk of an initial recommendation for additional
workup between the racial and ethnic groups, compared with normal- or short-interval follow-
up. For diagnostic examinations, we calculated the relative risk of a final recommendation for
“invasive workup” (biopsy, FNA, or surgical consultation) compared with normal- or short-
interval follow-up; we excluded recommendations for additional imaging, clinical exam, or
other workup NOS. We tested for an interaction between race and ethnicity and both symptom
types (lump/symptoms other than lump/none) and presence of symptoms.
Standard definitions for true positive (TP), false positive (FP), true negative (TN), and false
negative (FN) were calculated using the 12-month follow-up period [19]. All the analyses were
run using SAS V9.1 (Cary, NC).
Results
Our sample included 73,353 (73.6%) women seen for a first screening mammogram and 26,262
(26.4%) for a first diagnostic mammogram; the majority of first mammograms were for
screening across all racial/ethnic groups (69% for AA, 71% for Hispanic, 74% for white, and
81% for Asian women). Overall, the women who first underwent screening mammography
tended to be older (aged 35–39), college educated, and reported a first-degree family history
of breast cancer, compared to the women who first underwent diagnostic mammography.
First screening mammograms
African American and Hispanic women were more likely to be <35 years and less frequently
reported a college degree than white and Asian women (Table 1). AA women were least likely
to report a family history of breast cancer.
Overall, 11.3% of women undergoing a first screening mammogram reported symptoms, most
commonly a lump (5.3%). AA and Hispanic women reported symptoms more frequently than
did white and Asian women. Asian women were much more likely to be classified with
extremely dense breasts than other women.
Recommendations for additional workup ranged from 10.8% for Asian to 15.7% for AA
women. There was no interaction between race and ethnicity, or presence or type of symptoms
for the recommendations models for screening mammograms, and so only the main-effects
models are shown (Table 3). After a first screening mammogram, AA women were more likely
than white women to have an initial recommendation for additional workup compared to
normal- or short-interval follow-up [relative risk: 1.15 (95% CI: 1.07–1.23)]. Results remained
significant after post-hoc inclusion of breast density in the model.
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Over a 10-year period, 152 (<1%) of the women in our study were diagnosed with breast cancer
after a first screening mammogram, 26% of which were ductal carcinoma in situ. The percent
FP reflect variability across racial/ethnic groups, ranging from 10.4 to 14.1% (Table 4).
Considering the rate of TP to total first screening mammograms of younger women, a woman
has a likelihood of true positive of 1 in 363–1,122, depending on her race/ethnicity; she has a
likelihood of a FP of 1 in 7–10.
First diagnostic mammograms
African American and Hispanic women were less likely to report a college degree at the first
diagnostic mammogram than white and Asian women (Table 2). White and Hispanic women
reported a breast cancer family history more frequently than AA and Asian women.
Overall, 91.0% of the women reported symptoms. White women were more likely (71.8%)
than other women (57.7–63.6%) to report a lump; Asian women were less likely to report any
symptoms (77.4 vs. 89.9–91.9%). Asian women were much more likely to be classified with
extremely dense breasts than other women.
Recommendations for invasive workup ranged from 11.8% for white and Hispanic women to
20.2% for Asian women. There was no interaction between race and ethnicity, or presence, or
type of symptoms for the recommendations models for diagnostic mammograms, and so only
the main-effects models are shown (Table 3). After a first diagnostic mammogram, Asian
[relative risk: 1.44 (95% CI: 1.26–1.64)] and AA [relative risk: 1.30 (95% CI: 1.17–1.44)]
women were more likely than white women to be recommended for invasive workup. Results
remained significant after post-hoc inclusion of breast density in the model.
For first diagnostic mammograms of younger women, the overall TP was 1.5%, and slightly
higher for AA women at 2.3% (Table 4). The percent FP was substantively higher for Asian
women (18.2%) than other women (8.7–11.3%).
Discussion
Ours is the first study to prospectively describe mammography use in women younger than 40
by race/ethnicity. We interpret our results in the context of the literature, and formulate
hypotheses for future research based on our findings.
First screening mammograms
In our study, AA women are more likely to be recommended for further testing with no
clinically significant difference in TP results. This is consistent with a finding for women ≥40,
that a greater percentage of AA women than white women were recommended for biopsy after
a positive screening mammogram [20]. In our study, AA women have a TP to total screening
mammography rate of 1 in 363, about twice the rate as white women, and a FP rate of 1 in 7.
While our FP results did not vary substantially by race/ethnicity, their impact might. Among
AA women ≥40, abnormal or inconclusive results may be less effectively communicated than
normal results [21]. Only 80% of AA and 71% of Hispanic women reported being likely or
very likely to continue screening mammography after receiving FP results, compared to 93%
of white women [22]. Women who begin mammography screening prior to 40 face potential
harms from these first exams, but also from the cumulative risk of FP results from ongoing
regular mammography [23,24]. Therefore, future research should examine whether early
mammography use contributes to a differential impact on mammography use after 40 by race/
ethnicity given potential variation in the impact of FP results and recommendations for
additional invasive testing.
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Overall, 74% of these first mammograms were for screening purposes. Most women in our
sample seen for a first mammogram<40 had normal mammograms and were recommended
for normal interval follow-up. In addition to the potential harms associated with FP results,
other important harms to be considered in screening younger women include an increase in
radiation exposure. One study estimated the risk of radiation-induced breast cancer from early
mammography screening, finding no net benefit from annual mammography screening at ages
25–29, zero or small benefit at ages 30–34, and some benefit at ≥35 for BRCA mutation carriers
[25]. Another study estimated that a decade of annual screening mammography before age 40
for all women would result in a net increase in radiation-induced breast cancer deaths [26].
First diagnostic mammograms
In diagnostic mammograms, AA and Asian women are having 4.8–8.1% more
recommendations for invasive workup than white and Hispanic women, with an absolute
difference of a TP of <1%. Fibroadenomas are more common in younger AA women [27,
28]. Asian women are more likely to have extremely dense breasts. That women with dense
breasts tend to have lower mammography specificity [2] may partly explain why Asian women
in particular had a much higher percentage of diagnostic FP. Our overall diagnostic FP results
of 9.6% are twice that of the 4.9% for women aged<40 in another study [29], which may be
explained by the disparity in sample selections. The above-cited study sample included
radiologists from three mammography registries who responded to a survey, while our study
sample was derived from the records of women seen for first mammograms among seven
registries.
Women with breast problems
In our study, 91% of women at diagnostic and 11% at screening mammograms reported
symptoms. As breast problems at a screening mammogram are contrary to standard definitions,
we conducted a post-hoc analysis to examine racial/ethnic differences in mammography
indication (diagnostic compared to screening), adjusting for registry site, age (using a cubic b-
spline with 3 knots), examination year, and first-degree family history of breast cancer (yes/
no/unknown). We fitted a single model for indication, and included an interaction term for
race/ethnicity and the presence of symptoms (yes/no), which was significant (P < 0.001).
Therefore, we report the model results stratified by the presence of symptoms. We later
examined the stratified model with adjustment for education; this did not substantively alter
the results.
Among the women reporting symptoms, minority women were slightly less likely than white
women to have a diagnostic rather than screening indication [Hispanic: relative risk (RR) =
0.94 (95% CI: 0.92–0.97); Asian: RR = 0.95 (95% CI: 0.91–0.99); and AA: RR = 0.96 (95%
CI: 0.94–0.98)]. Women who report symptoms at a screening mammogram may have different
patterns of mammography access, such as self-referral, not receiving adequate pre-
mammography breast examinations, or may be more likely to access care through a program
for disadvantaged women. For example, the National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) is an avenue for low-income and uninsured U.S. women to
access breast and cervical cancer screening [30]. From 1995 to 2002, the NBCCEDP sponsored
28,965 first mammograms for women aged <40 in the United States [30]. Similar to our study,
in their analysis of women aged ≥40, these authors’ report included initial mammograms as
screening, even when symptomatic. An important avenue for future research would be to better
understand the circumstances surrounding women arriving for a screening mammogram with
reported symptoms.
Among the women not reporting symptoms, Hispanic and AA women were significantly more
likely than white women to have a diagnostic indication [Hispanic: RR = 1.37 (95% CI: 1.20–
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1.57); Asian: RR = 1.15 (95% CI: 1.00–1.31); AA: RR = 1.33 (95% CI: 1.16–1.53)]. We
considered three explanations for these findings. First, a woman at the time of a diagnostic
mammogram may have symptoms but not report them. This is consistent with the literature on
low health literacy being associated with poor communication between patients and providers
[31], and being higher on average among white and Asian than among AA and Hispanic adults
[31]. Second, these women may have healthcare disparities, where mammography access was
facilitated by the referring physician, such as (a) for third-party payment [32,33], given that
insurance providers cover diagnostic but not screening mammography in younger women, or
(b) in order to increase patient compliance, although diagnostic testing is often completed the
same day, screening mammography may require later follow-up testing. Third, these women
may have been evaluated with a clinical breast examination, where the provider found
something of concern but the woman did not exhibit symptoms.
Strengths and limitations
These BCSC data are rich in their racial/ethnic diversity, geographical variation, general
representation of the U.S. population [34], and prospective collection of community-based
practice data. However, a number of limitations warrant mention. First, these BCSC data cannot
finely define breast cancer risk, such as identifying women with BRCA1/BRCA2 mutations
or evaluation of risk based on a comprehensive family history pedigree [35]. However,
collecting breast cancer history on second degree relatives or the age at diagnosis of affected
relatives may not substantially improve the ability to assess which individuals are at high risk
for breast cancer, at least among women ≥40 [36]. One previous study suggests only about 3%
of first primary breast cancers detected in younger women were among asymptomatic women
with a positive family history [37]. In another study of younger women, all cancers found were
in symptomatic women with no family history of breast cancer [38]. Second, while these data
are supported by a rigorous, ongoing quality control practice in addition to the strong
collaboration and expertise within the BCSC, the potential for some variation in data capture
exists by site. Therefore, we report the percentage of missing data for consideration in
interpreting our results. For example, given high amounts of missing data for reported pain and
discharge symptoms, it is difficult to derive a meaningful understanding of these symptoms
by race/ethnicity. Third, we consider these findings somewhat exploratory and they deserve
confirmation in other studies with other community-based practices. Finally, we were unable
to distinguish women coming in early (e.g. age 39) for their 40-year screening mammogram
from those receiving early mammography for other reasons; however, our findings reflect
clinical practice.
Conclusions
This study is the first to prospectively describe first mammography use in women younger than
40 by race/ethnicity, using data from a nationally representative sample of 99,615 women from
community-based practice. Our findings suggest racial/ethnic variation at multiple points of
care over the course of an early first mammogram, such as at indication, recommendations,
and outcomes, the implications of which warrant further investigation. The fact that 74% of
these first mammograms were indicated for screening purposes highlights avenues for
additional study of motivating factors for these practice patterns and understanding of the
implications of early mammography use.
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Table 3
Risk of recommendation for additional workup or biopsy/FNA/surgical consultation compared to normal/short-
interval follow-up at the first mammogram for women aged <40, BCSC data 1996–2005
First screening mammograma,b First diagnostic mammograma,b
RR (95% CI) RR (95% CI)
Race/ethnicity
 Hispanic 1.06 (0.99–1.13) 1.12 (0.99–1.27)
 Asian 0.91 (0.83–1.00) 1.44 (1.26–1.64)
 AA 1.15 (1.07–1.23) 1.30 (1.17–1.44)
 White Referent Referent
Model n 70,709 19,711
Racial/ethnic categories are mutually exclusive representations of non-Hispanic African American (AA), non-Hispanic white, Asian, and Hispanic
BCSC Breast Cancer Surveillance Consortium, RR relative risk, CI confidence interval
a
Initial recommendation for additional workup (additional imaging, clinical exam, biopsy/FNA/surgical consultation, other workup NOS) of screening
mammograms; final recommendation for biopsy/FNA/surgical consultation for diagnostic mammograms
b
Adjusted for registry site, age (using a cubic b-spline with 3 knots), first-degree family history of breast cancer (yes/no/unknown), examination year,
and self-reported breast symptoms (yes/no)
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